Basedov-Thyrotoxic heart

Graves-thyrotoxic heart: a look at cardiac disorders in hyperthyroidism

Introduction:
Graves-thyrotoxic heart is one of the manifestations of hyperthyroidism, a pathological condition characterized by excessive activity of the thyroid gland and an excess of thyroid hormones in the body. Hyperthyroidism can have a significant impact on the cardiovascular system, leading to cardiac abnormalities and threatening the patient's general condition. In this article we will consider the concept of Graves-thyrotoxic heart, its main manifestations and consequences, as well as methods of treating this condition.

Definition of Graves-thyrotoxic heart:
Graves-thyrotoxic heart, also known as thyrotoxic heart, is a complex of cardiac changes associated with hyperthyroidism. Hyperthyroidism causes an increase in the production and release of thyrotoxic hormones, such as triiodothyronine (T3) and thyroxine (T4), which have negative effects on the heart and blood vessels. Graves-thyrotoxic heart disease involves several characteristic changes in cardiac structure and function.

Main manifestations and consequences:
Graves-thyrotoxic heart can manifest itself with a variety of symptoms and lesions of the cardiovascular system. One of the most common symptoms is a heartbeat that becomes fast and irregular. Patients may also experience angina, arrhythmias, increased blood pressure, and increased cardiac workload. In some cases, heart failure may develop, which can lead to serious complications.

Treatment and management:
Treatment for Graves-thyrotoxic heart disease is aimed at controlling thyroid hormone levels and relieving symptoms of heart problems. The main treatment method is to normalize thyroid function with antithyroid drugs such as thiamazole or propylthiouracil. These drugs block the synthesis of thyroid hormones and help reduce the level of thyroid hormones in the body. Severe heart problems may require additional treatment, including antiarrhythmic drugs or surgery.

Conclusion:
Heart thyrotoxicity is a cardiac manifestation of hyperthyroidism and can have serious consequences for the patient's health. Understanding this condition and its relationship to excess thyroid hormones allows for the development of effective treatment and management strategies. Early detection and timely treatment of cardiac abnormalities in Graves-thyrotoxic heart are important to prevent serious complications and improve the quality of life of patients.